NP “We are very pleased with the MHRA’s confi
Post# of 155320
(Total Views: 597)
Posted On: 08/20/2020 7:13:04 AM
Re: Boatbuilder #50796
NP
“We are very pleased with the MHRA’s confidence in leronlimab to initiate enrollment of patients in the U.K. for our current CD12 protocol. CytoDyn recently requested “fast track approval” from the MHRA for its completed Phase 2 COVID-19 trial for the mild-to-moderate population, with strong efficacy and safety data.”
Guess depends on definition of fast track. Sounds like it was expected. Approval to none past phase 2 immediately
“We are very pleased with the MHRA’s confidence in leronlimab to initiate enrollment of patients in the U.K. for our current CD12 protocol. CytoDyn recently requested “fast track approval” from the MHRA for its completed Phase 2 COVID-19 trial for the mild-to-moderate population, with strong efficacy and safety data.”
Guess depends on definition of fast track. Sounds like it was expected. Approval to none past phase 2 immediately
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
LETS GO!!!